Antibiotics are a crucial tool in the fight against bacterial infections. But the World Health Organization has long warned ...

AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

Make your antibiotic medication as effective as possible by getting these answers before you leave the doctor's office or ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

Packets of one antibiotic medication are being recalled from suppliers due to an extra tablet found in some batches.

NORTH CHICAGO, Ill. - The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam) for the ...

Batches of antibiotic medication are being recalled from suppliers after they were found to contain an extra tablet.

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...

AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...

With antibiotic resistance rising, any novel drugs that are developed are invariably reserved for last-line use when other drugs have failed, meaning the number of patient eligible to get them is ...